These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 455300

  • 21. Maytansine-resistant mutants of Chinese hamster ovary cells with an alteration in alpha-tubulin.
    Schibler MJ, Cabral FR.
    Can J Biochem Cell Biol; 1985 Jun; 63(6):503-10. PubMed ID: 4041962
    [Abstract] [Full Text] [Related]

  • 22. S1-phase cells of the leukemic cell cycle sensitive to 1-beta-D-arabinofuranosylcytosine at a high-dose level.
    Smets LA, Homan-Blok J.
    Cancer Res; 1985 Jul; 45(7):3113-7. PubMed ID: 4005848
    [Abstract] [Full Text] [Related]

  • 23. Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells.
    Ozawa S, Sugiyama Y, Mitsuhashi J, Inaba M.
    Cancer Res; 1989 Jul 15; 49(14):3823-8. PubMed ID: 2736524
    [Abstract] [Full Text] [Related]

  • 24. Minimal single-agent activity of maytansine in refractory breast cancer: a Southwest Oncology Group study.
    Neidhart JA, Laufman LR, Vaughn C, McCracken JD.
    Cancer Treat Rep; 1980 Jul 15; 64(4-5):675-7. PubMed ID: 7427953
    [Abstract] [Full Text] [Related]

  • 25. Flow microfluorimetric analysis of sensitive and resistant leukemia L1210 following 1-beta-D-arabinofuranosylcytosine in vivo.
    Alabaster O, Bunnag B.
    Cancer Res; 1976 Aug 15; 36(8):2744-9. PubMed ID: 1277184
    [Abstract] [Full Text] [Related]

  • 26. Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells.
    Hennequin C, Giocanti N, Balosso J, Favaudon V.
    Cancer Res; 1994 Apr 01; 54(7):1720-8. PubMed ID: 8137287
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias.
    Shiozawa K, Nakanishi T, Tan M, Fang HB, Wang WC, Edelman MJ, Carlton D, Gojo I, Sausville EA, Ross DD.
    Clin Cancer Res; 2009 Mar 01; 15(5):1698-707. PubMed ID: 19223502
    [Abstract] [Full Text] [Related]

  • 30. Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.
    Adams EG, Crampton SL, Bhuyan BK.
    Cancer Res; 1981 Dec 01; 41(12 Pt 1):4981-7. PubMed ID: 6458356
    [Abstract] [Full Text] [Related]

  • 31. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells.
    Eisman JA, Sutherland RL, McMenemy ML, Fragonas JC, Musgrove EA, Pang GY.
    J Cell Physiol; 1989 Mar 01; 138(3):611-6. PubMed ID: 2925799
    [Abstract] [Full Text] [Related]

  • 32. Cell line and schedule-dependent cytotoxicity of paclitaxel (Taxol): role of the solvent Cremophor EL/ethanol.
    Cordes N, Plasswilm L.
    Anticancer Res; 1998 Mar 01; 18(3A):1851-7. PubMed ID: 9673415
    [Abstract] [Full Text] [Related]

  • 33. Maytansine action on fast axoplasmic transport and the ultrastructure of vagal axons.
    Donoso JA, Watson DF, Heller-Bettinger IE, Samson FE.
    Cancer Res; 1978 Jun 01; 38(6):1633-7. PubMed ID: 77186
    [Abstract] [Full Text] [Related]

  • 34. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
    Sakoff JA, Howitt IJ, Ackland SP, McCluskey A.
    Cancer Chemother Pharmacol; 2004 Mar 01; 53(3):225-32. PubMed ID: 14648018
    [Abstract] [Full Text] [Related]

  • 35. Effect of recombinant tumor necrosis factor on HL-60 cells: cell-cycle specificity and synergism with actinomycin D.
    Darzynkiewicz Z, Carter SP, Old LJ.
    J Cell Physiol; 1987 Mar 01; 130(3):328-35. PubMed ID: 3470296
    [Abstract] [Full Text] [Related]

  • 36. [Effect of triptolide on cytokinetics of HeLa cells].
    Xu JH, Li CC, Huang ZQ.
    Zhongguo Yao Li Xue Bao; 1989 Nov 01; 10(6):550-3. PubMed ID: 2641856
    [Abstract] [Full Text] [Related]

  • 37. Schedule dependence of the interaction of radiation and Taxol in HeLa cells.
    Talwar N, Redpath JL.
    Radiat Res; 1997 Jul 01; 148(1):48-53. PubMed ID: 9216618
    [Abstract] [Full Text] [Related]

  • 38. Increasing 1-beta-D-arabinofuranosylcytosine efficacy by scheduled dosing intervals based on direct measurements of bone marrow cell kinetics.
    Ubezio P, Tagliabue G, Schechter B, Agur Z.
    Cancer Res; 1994 Dec 15; 54(24):6446-51. PubMed ID: 7987841
    [Abstract] [Full Text] [Related]

  • 39. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
    Schwartz SA, Morgenstern B, Capizzi RL.
    Cancer Res; 1982 Jun 15; 42(6):2191-7. PubMed ID: 7074600
    [Abstract] [Full Text] [Related]

  • 40. Action of lycurim and pyrazofurin on hepatoma 3924A cells in culture.
    Ban J, Olah E, Werber G.
    Cancer Treat Rep; 1982 Feb 15; 66(2):343-9. PubMed ID: 6895716
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.